Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis
Through structure-based drug design and parallel synthesis, we have discovered a novel series of nonpeptidic phenyl-based thrombin inhibitors using oxyguanidines as guanidine bioisosteres. These compounds have been found to be highly potent, highly selective, and orally bioavailable.
Lu, Tianbao,Markotan, Thomas,Coppo, Frank,Tomczuk, Bruce,Crysler, Carl,Eisennagel, Stephen,Spurlino, John,Gremminger, Lisa,Soll, Richard M.,Giardino, Edward C.,Bone, Roger
p. 3727 - 3731
(2007/10/03)
More Articles about upstream products of 245116-23-8